Edinburgh
United Kingdom
University of Edinburgh - Edinburgh Cancer Centre
breast cancer, endocrine therapy, everolimus, circadian rhythm, intake timing
Breast cancer, endocrine therapy, everolimus, Circadian rhythm, intake timing
breast cancer, radiotherapy, local recurrence, overall survival, long term
Biomarkers, Tumor/genetics, Breast Neoplasms/radiotherapy, Breast Neoplasms/surgery, Neoplasm Recurrence, Local/diagnosis, Patient selection, Prognosis, Radiotherapy, Adjuvant/adverse effects
COVID-19, SARscov2, Cancer, chemotherapy, administrative records, immunity
Climate change, Sustainability, Clinical Trial, breast cancer